Largest Diagnostics & Research Companies by Market Cap
The Diagnostics & Research sector has 167 publicly listed stocks with a combined market cap of $1.06 Trillion. Thermo Fisher Scientific Inc leads the sector with a market cap of $224.59 Billion. This ranking covers all Diagnostics & Research stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.06 Trillion
Companies Listed
167
Largest Company
Thermo Fisher Scientific …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Thermo Fisher Scientific Inc
NYSE:TMO |
$224.59 Billion | $224.59 Billion | USA | $641.39 | +4.53% | +4.50% | 38.02 Million |
| 2 |
Danaher Corporation
NYSE:DHR |
$147.88 Billion | $147.88 Billion | USA | $209.36 | +3.01% | +0.82% | 73.57 Million |
| 3 |
WuXi AppTec Co Ltd
SHG:603259 |
$56.70 Billion | CN¥387.49 Billion | China | CN¥156.67 | -1.38% | +2.23% | 1.06 Billion |
| 4 |
Natera Inc
NASDAQ:NTRA |
$47.01 Billion | $47.01 Billion | USA | $350.78 | +2.63% | +6.89% | 28.08 Million |
| 5 |
Agilent Technologies Inc
NYSE:A |
$42.53 Billion | $42.53 Billion | USA | $150.27 | +2.36% | -0.39% | 50.76 Million |
| 6 |
LONZA GROUP UNSP.ADR 1/10
F:LO3A |
$41.04 Billion | €35.10 Billion | Germany | €54.50 | +0.00% | -3.54% | 230.00 |
| 7 |
IDEXX Laboratories Inc
NASDAQ:IDXX |
$40.24 Billion | $40.24 Billion | USA | $510.73 | +0.23% | -4.60% | 11.51 Million |
| 8 |
IQVIA Holdings Inc
NYSE:IQV |
$39.29 Billion | $39.29 Billion | USA | $269.67 | +1.51% | +0.71% | 29.98 Million |
| 9 |
Lonza Group AG
SW:LONN |
$37.10 Billion | CHF29.35 Billion | Switzerland | CHF537.20 | +0.56% | -4.17% | 2.92 Million |
| 10 |
Waters Corporation
NYSE:WAT |
$34.91 Billion | $34.91 Billion | USA | $417.09 | +1.73% | +1.88% | 14.93 Million |
| 11 |
Mettler-Toledo International Inc
NYSE:MTD |
$26.66 Billion | $26.66 Billion | USA | $1330.40 | +3.47% | -1.10% | 4.04 Million |
| 12 |
Quest Diagnostics Incorporated
NYSE:DGX |
$26.31 Billion | $26.31 Billion | USA | $247.08 | +3.86% | +4.19% | 21.36 Million |
| 13 |
Labcorp Holdings Inc.
MX:LH |
$22.45 Billion | MX$390.06 Billion | Mexico | MX$4705.14 | +0.00% | -4.17% | 1.73K |
| 14 |
Laboratory Corporation of America Holdings
NYSE:LH |
$21.71 Billion | $21.71 Billion | USA | $323.97 | +2.75% | -0.89% | 15.33 Million |
| 15 |
EXACT Sciences Corporation
NASDAQ:EXAS |
$19.80 Billion | $19.80 Billion | USA | $1819.87 | +0.25% | -2.61% | 37.42 Million |
| 16 |
Illumina Inc
NASDAQ:ILMN |
$18.34 Billion | $18.34 Billion | USA | $222.29 | +6.76% | +1.87% | 43.37 Million |
| 17 |
Medpace Holdings Inc
NASDAQ:MEDP |
$16.36 Billion | $16.36 Billion | USA | $620.48 | +4.21% | +4.94% | 4.77 Million |
| 18 |
ICON PLC
NASDAQ:ICLR |
$12.90 Billion | $12.90 Billion | USA | $172.45 | +2.08% | +4.61% | 16.40 Million |
| 19 |
Charles River Laboratories
NYSE:CRL |
$12.77 Billion | $12.77 Billion | USA | $272.88 | -0.08% | -5.41% | 20.66 Million |
| 20 |
WuXi AppTec Co. Ltd
F:WX8 |
$12.76 Billion | €10.91 Billion | Germany | €21.38 | -2.15% | +2.59% | 3.68K |
| 21 |
Guardant Health Inc
NASDAQ:GH |
$12.69 Billion | $12.69 Billion | USA | $175.65 | +4.65% | +8.82% | 45.71 Million |
| 22 |
Revvity Inc.
NYSE:RVTY |
$12.20 Billion | $12.20 Billion | USA | $140.19 | +9.11% | +7.66% | 38.47 Million |
| 23 |
Eurofins Scientific SE
F:ESF0 |
$11.18 Billion | €9.56 Billion | Germany | €59.14 | +0.03% | +0.92% | 2.33K |
| 24 |
Eurofins Scientific SE
PA:ERF |
$10.22 Billion | €8.74 Billion | France | €73.48 | +1.83% | +2.63% | 6.68 Million |
| 25 |
Biomerieux SA
PA:BIM |
$8.48 Billion | €7.25 Billion | France | €72.80 | +1.75% | +0.34% | 3.58 Million |
| 26 |
Qiagen NV
NYSE:QGEN |
$7.79 Billion | $7.79 Billion | USA | $42.48 | +1.43% | -2.28% | 62.14 Million |
| 27 |
ICON Public Limited Company
F:IJF |
$7.52 Billion | €6.43 Billion | Germany | €148.90 | +1.12% | +7.28% | 338.00 |
| 28 |
Sonic Healthcare Ltd
AU:SHL |
$6.77 Billion | AU$9.56 Billion | Australia | AU$19.35 | +1.57% | -1.12% | 99.67 Million |
| 29 |
Hangzhou Tigermed Consulting
SHE:300347 |
$6.03 Billion | CN¥41.18 Billion | China | CN¥55.81 | -1.05% | +13.30% | 458.50 Million |
| 30 |
RadNet Inc
NASDAQ:RDNT |
$6.01 Billion | $6.01 Billion | USA | $77.12 | +2.16% | +4.63% | 15.78 Million |
| 31 |
Sotera Health Co
NASDAQ:SHC |
$5.42 Billion | $5.42 Billion | USA | $18.98 | +2.48% | +0.42% | 51.88 Million |
| 32 |
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN |
$4.45 Billion | $4.45 Billion | USA | $104.27 | +3.42% | +4.91% | 13.69 Million |
| 33 |
Joinn Laboratories(China)Co
SHG:603127 |
$3.90 Billion | CN¥26.68 Billion | China | CN¥42.32 | -1.12% | -1.17% | 831.04 Million |
| 34 |
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB |
$3.44 Billion | Rs318.33 Billion | India | Rs1906.40 | -0.14% | +1.54% | 4.66 Million |
| 35 |
Veracyte Inc
NASDAQ:VCYT |
$3.23 Billion | $3.23 Billion | USA | $40.14 | -2.60% | -5.62% | 30.22 Million |
| 36 |
GRAIL, LLC
NASDAQ:GRAL |
$3.08 Billion | $3.08 Billion | USA | $75.89 | +0.48% | -5.54% | 16.10 Million |
| 37 |
CareDx Inc
NASDAQ:CDNA |
$2.59 Billion | $2.59 Billion | USA | $52.64 | +0.52% | +3.46% | 25.99 Million |
| 38 |
GeneDx Holdings Corp.
NASDAQ:WGS |
$2.30 Billion | $2.30 Billion | USA | $94.64 | +5.46% | +10.06% | 11.96 Million |
| 39 |
Fleury S.A.
SA:FLRY3 |
$2.27 Billion | R$11.57 Billion | Brazil | R$21.28 | -0.56% | +5.50% | 101.84 Million |
| 40 |
BGI Genomics Co Ltd
SHE:300676 |
$2.23 Billion | CN¥15.21 Billion | China | CN¥36.36 | -0.98% | -1.41% | 267.82 Million |
| 41 |
NeoGenomics Inc
NASDAQ:NEO |
$2.23 Billion | $2.23 Billion | USA | $18.41 | +6.29% | +5.80% | 38.44 Million |
| 42 |
Vimian Group AB
ST:VIMIAN |
$1.94 Billion | Skr18.07 Billion | Sweden | Skr34.35 | -1.15% | +0.73% | 14.90 Million |
| 43 |
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882 |
$1.82 Billion | CN¥12.46 Billion | China | CN¥26.90 | -2.11% | +2.01% | 234.43 Million |
| 44 |
Vijaya Diagnostic Centre Limited
NSE:VIJAYA |
$1.67 Billion | Rs154.70 Billion | India | Rs1502.00 | +0.21% | -0.23% | 4.67 Million |
| 45 |
Zhejiang DiAn Diagnostics Co
SHE:300244 |
$1.65 Billion | CN¥11.25 Billion | China | CN¥18.00 | +1.98% | -0.06% | 670.23 Million |
| 46 |
Syngene International Limited
NSE:SYNGENE |
$1.65 Billion | Rs152.19 Billion | India | Rs378.85 | -0.99% | -4.23% | 12.55 Million |
| 47 |
Freenome, Inc. Common stock
NASDAQ:FRNM |
$1.57 Billion | $1.57 Billion | USA | $14.64 | -2.14% | -10.24% | 14.73 Million |
| 48 |
Personalis Inc
NASDAQ:PSNL |
$1.51 Billion | $1.51 Billion | USA | $16.10 | -1.17% | -6.40% | 80.61 Million |
| 49 |
Opko Health Inc
NASDAQ:OPK |
$1.17 Billion | $1.17 Billion | USA | $1.57 | +0.64% | -4.27% | 68.78 Million |
| 50 |
Castle Biosciences Inc
NASDAQ:CSTL |
$1.00 Billion | $1.00 Billion | USA | $35.50 | +6.16% | +7.87% | 7.89 Million |
| 51 |
Beijing Strong Biotechnologies Inc
SHE:300406 |
$961.77 Million | CN¥6.57 Billion | China | CN¥11.21 | -1.58% | -3.86% | 119.86 Million |
| 52 |
Amoy Diagnostics Co Ltd
SHE:300685 |
$956.17 Million | CN¥6.53 Billion | China | CN¥16.75 | -0.95% | -2.28% | 207.83 Million |
| 53 |
Thyrocare Technologies Limited
NSE:THYROCARE |
$937.15 Million | Rs86.66 Billion | India | Rs544.45 | -0.96% | -5.50% | 15.66 Million |
| 54 |
Clinica Baviera
MC:CBAV |
$842.36 Million | €720.51 Million | Spain | €56.60 | +0.00% | -4.07% | 34.61K |
| 55 |
Shanghai Runda Med Tech Co
SHG:603108 |
$821.53 Million | CN¥5.61 Billion | China | CN¥9.30 | -1.38% | -5.58% | 362.52 Million |
| 56 |
Maccura Biotechnology Co Ltd
SHE:300463 |
$792.80 Million | CN¥5.42 Billion | China | CN¥8.96 | -1.86% | -3.45% | 170.50 Million |
| 57 |
HANGZHOU TIGERMED CO. H 1
F:5HZ1 |
$699.58 Million | €598.39 Million | Germany | €4.86 | +8.97% | +14.08% | 0.00 |
| 58 |
Cowealth Medical China Co.Ltd.
SHG:603122 |
$689.07 Million | CN¥4.71 Billion | China | CN¥11.83 | -2.15% | -14.03% | 621.09 Million |
| 59 |
Diagnósticos da América S.A
SA:DASA3 |
$676.83 Million | R$3.45 Billion | Brazil | R$2.76 | -2.47% | -2.13% | 27.90 Million |
| 60 |
Integral Diagnostics Ltd
AU:IDX |
$609.54 Million | AU$861.46 Million | Australia | AU$2.31 | +0.43% | -0.86% | 28.53 Million |
| 61 |
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060 |
$595.46 Million | CN¥4.07 Billion | China | CN¥10.16 | -2.50% | -2.78% | 673.42 Million |
| 62 |
Guangdong Hybribio Biotech Co Ltd
SHE:300639 |
$535.46 Million | CN¥3.66 Billion | China | CN¥5.66 | -2.25% | -3.58% | 355.26 Million |
| 63 |
Ningbo MedicalSystem Biotechnology Co Ltd
SHE:300439 |
$526.39 Million | CN¥3.60 Billion | China | CN¥9.36 | -0.95% | -0.74% | 90.55 Million |
| 64 |
Wuhan Thalys Med Tech Co Ltd
SHG:603716 |
$522.04 Million | CN¥3.57 Billion | China | CN¥15.80 | -2.89% | -10.33% | 342.97 Million |
| 65 |
Fulgent Genetics Inc
NASDAQ:FLGT |
$514.81 Million | $514.81 Million | USA | $21.28 | +3.05% | +7.86% | 6.57 Million |
| 66 |
Lumibird SA
PA:LBIRD |
$489.86 Million | €419.00 Million | France | €25.65 | -0.58% | +0.98% | 611.48K |
| 67 |
Berry Genomics Co Ltd
SHE:000710 |
$432.47 Million | CN¥2.96 Billion | China | CN¥8.36 | -2.90% | -4.13% | 523.44 Million |
| 68 |
SMO ClinPlus Co. Ltd.
SHE:301257 |
$424.17 Million | CN¥2.90 Billion | China | CN¥36.69 | -1.66% | -3.85% | 111.76 Million |
| 69 |
Voxel S.A.
WAR:VOX |
$409.87 Million | zł1.49 Billion | Poland | zł141.80 | -2.07% | +0.57% | 242.33K |
| 70 |
Australian Clinical Labs Ltd
AU:ACL |
$360.33 Million | AU$509.26 Million | Australia | AU$2.82 | +3.30% | +1.81% | 21.74 Million |
| 71 |
Chemclin Diagnostics Co. Ltd. A
SHG:688468 |
$353.93 Million | CN¥2.42 Billion | China | CN¥6.03 | -2.58% | -5.04% | 66.00 Million |
| 72 |
Prenetics Global Ltd
NASDAQ:PRE |
$351.91 Million | $351.91 Million | USA | $23.08 | -4.31% | -9.28% | 6.61 Million |
| 73 |
Myriad Genetics Inc
NASDAQ:MYGN |
$321.38 Million | $321.38 Million | USA | $3.88 | +2.37% | +21.63% | 43.77 Million |
| 74 |
Metropolis Healthcare Limited
NSE:METROPOLIS |
$320.91 Million | Rs29.67 Billion | India | Rs572.50 | -2.22% | -2.75% | 6.65 Million |
| 75 |
Integrated Diagnostics Holdings PLC
LSE:IDHC |
$318.57 Million | $318.57 Million | UK | $0.55 | +1.48% | -0.36% | 1.45 Million |
| 76 |
Vimta Labs Limited
NSE:VIMTALABS |
$297.70 Million | Rs27.53 Billion | India | Rs616.00 | -2.16% | -3.09% | 6.07 Million |
| 77 |
INTERGRATED DIA.H DL 025
F:8I8 |
$288.34 Million | €246.63 Million | Germany | €0.43 | +3.38% | +5.94% | 0.00 |
| 78 |
Biodesix Inc
NASDAQ:BDSX |
$285.72 Million | $285.72 Million | USA | $27.70 | +1.09% | +5.81% | 2.74 Million |
| 79 |
Spectral Med Inc
TO:EDT |
$265.63 Million | CA$367.21 Million | Canada | CA$1.27 | -1.55% | +0.79% | 982.96K |
| 80 |
Shanghai Rendu Biotechnology Co. Ltd. A
SHG:688193 |
$251.90 Million | CN¥1.72 Billion | China | CN¥42.96 | -4.75% | -8.75% | 10.54 Million |
| 81 |
Healius Ltd
AU:HLS |
$233.78 Million | AU$330.40 Million | Australia | AU$0.46 | +7.06% | -1.09% | 101.47 Million |
| 82 |
Monash Ivf Group Ltd
AU:MVF |
$208.15 Million | AU$294.17 Million | Australia | AU$0.76 | -3.82% | -7.93% | 21.96 Million |
| 83 |
Krsnaa Diagnostics Limited
NSE:KRSNAA |
$190.02 Million | Rs17.57 Billion | India | Rs541.65 | -1.53% | -3.28% | 1.73 Million |
| 84 |
Exagen Inc
NASDAQ:XGN |
$177.09 Million | $177.09 Million | USA | $7.49 | +1.90% | -1.19% | 6.70 Million |
| 85 |
Cancer Rop Co. Ltd.
KQ:180400 |
$157.75 Million | ₩232.78 Billion | Korea | ₩2365.00 | -0.63% | +4.42% | 1.69 Million |
| 86 |
Prodia Widyahusada Tbk PT
JK:PRDA |
$154.36 Million | Rp2.63 Trillion | Indonesia | Rp2810.00 | +0.00% | +1.44% | 26.99 Million |
| 87 |
Green Cross Lab Cell Corporation
KQ:144510 |
$142.78 Million | ₩210.68 Billion | Korea | ₩14020.00 | -1.48% | -7.15% | 1.06 Million |
| 88 |
Selvita S.A.
WAR:SLV |
$131.82 Million | zł478.98 Million | Poland | zł26.10 | -2.97% | -2.25% | 400.12K |
| 89 |
Insight Molecular Diagnostics Inc.
NASDAQ:IMDX |
$131.55 Million | $131.55 Million | USA | $4.02 | +0.00% | -2.66% | 5.12 Million |
| 90 |
Fonar Corporation
NASDAQ:FONR |
$117.84 Million | $117.84 Million | USA | $19.09 | +0.00% | +0.95% | 2.89 Million |
| 91 |
MDxHealth SA ADR
NASDAQ:MDXH |
$111.46 Million | $111.46 Million | USA | $2.17 | -4.82% | -6.06% | 5.64 Million |
| 92 |
Burning Rock Biotech Ltd
NASDAQ:BNR |
$102.95 Million | $102.95 Million | USA | $11.68 | +0.69% | -2.59% | 1.00 Million |
| 93 |
Centro de Imagem Diagnósticos S.A
SA:AALR3 |
$101.32 Million | R$516.37 Million | Brazil | R$3.39 | -1.74% | +2.73% | 961.20K |
| 94 |
Bionet
TWO:1784 |
$95.76 Million | NT$3.04 Billion | Taiwan | NT$58.50 | -0.17% | -2.66% | 1.53 Million |
| 95 |
Scope Fluidics SA
WAR:SCP |
$94.68 Million | zł344.01 Million | Poland | zł126.20 | -2.17% | +1.45% | 38.50K |
| 96 |
SCOPE FLUIDICS SA ZY-10
F:S84 |
$93.53 Million | €80.00 Million | Germany | €25.25 | -0.79% | +0.80% | 0.00 |
| 97 |
OncoCyte Corp
NASDAQ:OCX |
$90.37 Million | $90.37 Million | USA | $3.16 | +0.00% | +0.00% | 1.44 Million |
| 98 |
BioPorto
CO:BIOPOR |
$86.37 Million | Dkr552.03 Million | Denmark | Dkr1.12 | -3.46% | -6.69% | 6.16 Million |
| 99 |
Eurofins-Cerep SA
PA:ALECR |
$82.22 Million | €70.32 Million | France | €18200.00 | +0.00% | +0.00% | 6.00 |
| 100 |
JOONGANG DNM Co.Ltd
KQ:051980 |
$77.76 Million | ₩114.75 Billion | Korea | ₩1035.00 | -2.63% | +2.07% | 40.65 Million |
| 101 |
DIVA Laboratories Ltd
TWO:4153 |
$58.78 Million | NT$1.87 Billion | Taiwan | NT$31.80 | -0.31% | -1.09% | 260.68K |
| 102 |
Access Bio Inc
KQ:950130 |
$58.40 Million | ₩86.18 Billion | Korea | ₩2450.00 | -0.81% | -0.20% | 3.77 Million |
| 103 |
Pangaea Oncology S.A.
MC:PANG |
$53.87 Million | €46.08 Million | Spain | €1.43 | -4.67% | -4.67% | 5.10K |
| 104 |
Optipharm.CO.LTD
KQ:153710 |
$47.62 Million | ₩70.27 Billion | Korea | ₩4790.00 | +1.16% | -0.42% | 107.84K |
| 105 |
Cytogen Inc
KQ:217330 |
$47.21 Million | ₩69.67 Billion | Korea | ₩3020.00 | +0.83% | -1.15% | 1.35 Million |
| 106 |
Cryosite Ltd
AU:CTE |
$40.75 Million | AU$57.60 Million | Australia | AU$1.18 | +0.00% | -5.60% | 52.90K |
| 107 |
P&K Skin Research Center Co. Ltd
KQ:347740 |
$35.39 Million | ₩52.22 Billion | Korea | ₩1808.00 | +0.44% | -1.15% | 717.47K |
| 108 |
Precipio Inc
NASDAQ:PRPO |
$31.61 Million | $31.61 Million | USA | $27.16 | -0.26% | -0.88% | 4.12 Million |
| 109 |
Gencurix Inc
KQ:229000 |
$31.07 Million | ₩45.85 Billion | Korea | ₩1957.00 | +0.88% | +4.88% | 6.24 Million |
| 110 |
INIFY LABORATORIES AB
F:WY60 |
$30.74 Million | €26.29 Million | Germany | €0.41 | -0.49% | -9.37% | 0.00 |
| 111 |
Quantum Cyber N.V.
NASDAQ:QUCY |
$29.83 Million | $29.83 Million | USA | $1.31 | -0.76% | -17.61% | 20.70 Million |
| 112 |
Genoray Co. Ltd
KQ:122310 |
$27.66 Million | ₩40.82 Billion | Korea | ₩3360.00 | +1.82% | +1.82% | 985.87K |
| 113 |
Biocartis Group NV
BR:BCART |
$27.24 Million | €23.30 Million | Belgium | €0.29 | +0.00% | +0.00% | 0.00 |
| 114 |
NanoRepro AG
XETRA:NN6 |
$24.99 Million | €21.38 Million | Germany | €1.70 | -1.17% | -2.31% | 224.21K |
| 115 |
Microba Life Sciences Ltd
AU:MAP |
$23.27 Million | AU$32.88 Million | Australia | AU$0.05 | +0.00% | -1.82% | 2.98 Million |
| 116 |
GeneMatrix Inc
KQ:109820 |
$21.77 Million | ₩32.12 Billion | Korea | ₩1609.00 | +0.56% | -1.29% | 5.81 Million |
| 117 |
Diagnos Laboratorium Utama PT Tbk
JK:DGNS |
$19.19 Million | Rp327.50 Billion | Indonesia | Rp262.00 | -2.96% | -6.43% | 49.14 Million |
| 118 |
RHYTHM Biosciences Ltd
AU:RHY |
$18.57 Million | AU$26.24 Million | Australia | AU$0.08 | -2.44% | -5.88% | 5.09 Million |
| 119 |
Bcal Diagnostics Ltd
AU:BDX |
$18.52 Million | AU$26.18 Million | Australia | AU$0.07 | +0.00% | +5.97% | 2.81 Million |
| 120 |
bioAffinity Technologies, Inc.
NASDAQ:BIAF |
$17.63 Million | $17.63 Million | USA | $6.36 | -19.80% | -58.35% | 323.87 Million |
| 121 |
Inoviq Ltd
AU:IIQ |
$16.93 Million | AU$23.93 Million | Australia | AU$0.17 | +0.00% | -8.11% | 3.11 Million |
| 122 |
Enzo Biochem Inc
NYSE:ENZ |
$16.44 Million | $16.44 Million | USA | $0.54 | +0.00% | +0.00% | 1.75K |
| 123 |
SenzaGen AB
ST:SENZA |
$15.84 Million | Skr147.23 Million | Sweden | Skr4.99 | +4.39% | +2.67% | 439.32K |
| 124 |
INOVIQ LTD.
F:EGQ0 |
$13.99 Million | €11.97 Million | Germany | €0.09 | -1.73% | -2.30% | 0.00 |
| 125 |
Malaysian Genomics Resource
KLSE:0155 |
$13.83 Million | RM55.09 Million | Malaysia | RM0.37 | +0.00% | +0.00% | 1.89 Million |
| 126 |
AroCell AB
ST:AROC |
$13.39 Million | Skr124.39 Million | Sweden | Skr0.54 | +0.00% | +0.00% | 724.84K |
| 127 |
Advanced Biomed Inc. Common Stock
NASDAQ:ADVB |
$13.35 Million | $13.35 Million | USA | $8.08 | +3.86% | -13.44% | 5.29 Million |
| 128 |
NSN Co. Ltd
KQ:031860 |
$12.68 Million | ₩18.71 Billion | Korea | ₩693.00 | +17.26% | +15.69% | 50.75 Million |
| 129 |
Genetic Signatures Ltd
AU:GSS |
$11.73 Million | AU$16.58 Million | Australia | AU$0.07 | -9.88% | -9.88% | 11.52 Million |
| 130 |
Biomaxima
WAR:BMX |
$11.70 Million | zł42.52 Million | Poland | zł10.14 | -0.39% | -0.39% | 52.42K |
| 131 |
Immunovia publ AB
ST:IMMNOV |
$11.52 Million | Skr107.09 Million | Sweden | Skr0.16 | +1.40% | -5.01% | 88.91 Million |
| 132 |
Mainz Biomed BV
NASDAQ:MYNZ |
$9.49 Million | $9.49 Million | USA | $0.76 | -10.15% | -16.66% | 18.17 Million |
| 133 |
Check Cap Ltd
NASDAQ:CHEK |
$9.42 Million | $9.42 Million | USA | $139.00 | +0.72% | -2.80% | 22.52 Million |
| 134 |
Check-Cap Ltd
F:7CC |
$9.20 Million | €7.87 Million | Germany | €5.35 | +0.94% | +0.94% | 4.08K |
| 135 |
ENDRA Life Sciences Inc
NASDAQ:NDRA |
$8.68 Million | $8.68 Million | USA | $5.87 | +4.45% | -9.13% | 995.22K |
| 136 |
IZOTROPIC CORP.
F:1R3 |
$8.55 Million | €7.31 Million | Germany | €0.11 | -10.92% | -15.20% | 0.00 |
| 137 |
XWELL Inc.
NASDAQ:XWEL |
$7.13 Million | $7.13 Million | USA | $0.90 | -3.20% | -8.15% | 838.62K |
| 138 |
GENINCODE PLC LS -01
F:9PL |
$6.02 Million | €5.15 Million | Germany | €0.01 | +0.00% | -12.50% | 0.00 |
| 139 |
Avricore Health Inc
V:AVCR |
$5.48 Million | CA$7.58 Million | Canada | CA$0.06 | +0.00% | -7.69% | 1.49 Million |
| 140 |
Predilife
PA:ALPRE |
$4.67 Million | €4.00 Million | France | €1.02 | +0.00% | -17.74% | 13.51K |
| 141 |
Leveljump Healthcare Corp
V:JUMP |
$4.41 Million | CA$6.10 Million | Canada | CA$0.06 | +0.00% | +0.00% | 0.00 |
| 142 |
Genetic Technologies Ltd
AU:GTG |
$4.01 Million | AU$5.67 Million | Australia | AU$0.04 | +0.00% | +0.00% | 0.00 |
| 143 |
Applied DNA Sciences Inc
NASDAQ:APDN |
$3.99 Million | $3.99 Million | USA | $3.09 | +3.00% | +24.10% | 1.14 Million |
| 144 |
Euroespes S.A.
MC:EEP |
$3.95 Million | €3.38 Million | Spain | €0.34 | +0.00% | +0.00% | 0.00 |
| 145 |
Genetic Technologies Ltd
NASDAQ:GENE |
$3.71 Million | $3.71 Million | USA | $1965.70 | +0.40% | -2.11% | 18.23K |
| 146 |
StageZero Life Sciences Ltd
TO:SZLS |
$3.58 Million | CA$4.94 Million | Canada | CA$0.04 | +0.00% | +0.00% | 0.00 |
| 147 |
Centogene N.V.
NASDAQ:CNTGF |
$3.48 Million | $3.48 Million | USA | $0.12 | +0.00% | +0.00% | 126.40K |
| 148 |
iSpecimen Inc
NASDAQ:ISPC |
$3.35 Million | $3.35 Million | USA | $1.33 | -9.52% | -13.64% | 30.10 Million |
| 149 |
Telo Genomics Corp
V:TELO |
$3.27 Million | CA$4.52 Million | Canada | CA$0.05 | +0.00% | +0.00% | 1.37 Million |
| 150 |
Imagion Biosystems Ltd
AU:IBX |
$2.78 Million | AU$3.92 Million | Australia | AU$0.01 | +0.00% | +0.00% | 64.71 Million |
Track real-time market capitalization of largest public companies in the Diagnostics & Research industry. Compare marketcap, analyze stock performance, and discover leading diagnostics & research corporations. View all industries